BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 14577492)

  • 21. Does screening for prostate cancer identify clinically important disease?
    Feneley MR
    Ann R Coll Surg Engl; 1999 May; 81(3):207-14. PubMed ID: 10364958
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The significance of early detection for prostate cancer in mass screening].
    Kato M; Tammbo M; Yoshimatsu T; Ohta M; Kinjyo M; Noda H; Watanabe K; Miyata A; Murata A; Miura I; Yoneda T; Yoshii M; Okegawa T; Kojima M; Sayama T; Nutahara K; Higashihara E
    Nihon Hinyokika Gakkai Zasshi; 2001 Jan; 92(1):23-9. PubMed ID: 11235139
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of obesity on the diagnosis of prostate cancer using a modern extended biopsy scheme.
    Pruthi RS; Swords K; Schultz H; Carson CC; Wallen EM
    J Urol; 2009 Feb; 181(2):574-7; discussion 578. PubMed ID: 19084847
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early detection of prostate cancer by routine screening.
    Chodak GW; Schoenberg HW
    JAMA; 1984 Dec; 252(23):3261-4. PubMed ID: 6512929
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potentially advanced malignancies detected by screening for prostate carcinoma after an interval of 4 years.
    Postma R; Roobol M; Schröder FH; van der Kwast TH
    Cancer; 2004 Mar; 100(5):968-75. PubMed ID: 14983492
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of low free to total PSA ratio in prostate cancer screening: detection rates, clinical and pathological findings in Brazilian men with serum PSA levels <4.0 ng/mL.
    Faria EF; Carvalhal GF; dos Reis RB; Tobias-Machado M; Vieira RA; Reis LO; Nogueira L; Machado RD; Freitas CH; Magnabosco WJ; Mauad EC; Carvalho AL
    BJU Int; 2012 Dec; 110(11 Pt B):E653-7. PubMed ID: 22892057
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictive value of the anatomical location of ultrasound-guided systematic sextant prostate biopsies for the nodal status of patients with localized prostate cancer.
    Dunzinger M; Sega W; Madersbacher S; Schorn A
    Eur Urol; 1997; 31(3):317-22. PubMed ID: 9129923
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systematic prostatic biopsies in 100 men with no suspicion of cancer on digital rectal examination.
    Vallancien G; Prapotnich D; Veillon B; Brisset JM; Andre-Bougaran J
    J Urol; 1991 Nov; 146(5):1308-12. PubMed ID: 1719243
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of fine needle aspiration for detection of stage A prostatic carcinoma before transurethral resection of the prostate: a clinical trial.
    Agatstein EH; Hernandez FJ; Layfield LJ; Smith RB; deKernion JB
    J Urol; 1987 Sep; 138(3):551-3. PubMed ID: 3305990
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interval carcinomas in the European Randomized Study of Screening for Prostate Cancer (ERSPC)-Rotterdam.
    van der Cruijsen-Koeter IW; van der Kwast TH; Schröder FH
    J Natl Cancer Inst; 2003 Oct; 95(19):1462-6. PubMed ID: 14519752
    [TBL] [Abstract][Full Text] [Related]  

  • 31. American Cancer Society--National Prostate Cancer Detection Project. Results from multiple examinations using transrectal ultrasound, digital rectal examination, and prostate specific antigen.
    Mettlin C; Murphy GP; Ray P; Shanberg A; Toi A; Chesley A; Babaian R; Badalament R; Kane RA; Lee F
    Cancer; 1993 Feb; 71(3 Suppl):891-8. PubMed ID: 7679042
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prostate cancer screening using fine-needle aspiration cytology prior to open prostatectomy.
    Palmer LS; Laor E; Skinner WK; Tolia BM; Reid RE; Freed SZ
    Eur Urol; 1995; 27(2):96-8. PubMed ID: 7744165
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prostate carcinoma screening in the county of Tyrol, Austria: experience and results.
    Reissigl A; Horninger W; Fink K; Klocker H; Bartsch G
    Cancer; 1997 Nov; 80(9):1818-29. PubMed ID: 9351555
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Repeated screening for carcinoma of the prostate by digital rectal examination in a randomly selected population.
    Varenhorst E; Carlsson P; Capik E; Löfman O; Pedersen KV
    Acta Oncol; 1992; 31(8):815-21. PubMed ID: 1290631
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increasing the number of biopsies increases the concordance of Gleason scores of needle biopsies and prostatectomy specimens.
    Divrik RT; Eroglu A; Sahin A; Zorlu F; Ozen H
    Urol Oncol; 2007; 25(5):376-82. PubMed ID: 17826653
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patients with abnormal ultrasound of the prostate but normal digital rectal examination should be classified as having clinical stage T2 tumors.
    Tiguert R; Gheiler EL; Grignon DJ; Littrup PJ; Sakr W; Pontes JE; Wood DP
    J Urol; 2000 May; 163(5):1486-90. PubMed ID: 10751863
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adenocarcinoma of the prostate: results of routine urological screening.
    Thompson IM; Ernst JJ; Gangai MP; Spence CR
    J Urol; 1984 Oct; 132(4):690-2. PubMed ID: 6471214
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The eternal enigma in prostatic biopsy access route.
    Fabiani A; Principi E; Filosa A; Servi L
    Arch Ital Urol Androl; 2017 Oct; 89(3):245-246. PubMed ID: 28969413
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of digital rectal examination and biopsy results with the radical prostatectomy specimen.
    Obek C; Louis P; Civantos F; Soloway MS
    J Urol; 1999 Feb; 161(2):494-8; discussion 498-9. PubMed ID: 9915434
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stage A1 prostate cancer: follow-up with digital rectal exploration, prostate markers, fine-needle aspiration, ultrasonographically guided needle biopsy and biopsies of the residual prostate with resectoscope.
    Breda G; Silvestre P; Giunta A; Xausa D; Tamai A; Gherardi L
    Eur Urol; 1994; 25(2):116-8. PubMed ID: 7511104
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.